Skip to main content
Caplight Logo









Isogenica

Isogenica

Private
CambridgeHealthcare & Life Scienceshttps://isogenica.com/

Last Round

VC Round

May 6, 2008

Company Overview

Isogenica is a biotechnology company that operates as a contract research organization specializing in the discovery and engineering of small-format VHH single-domain antibodies for therapeutic and diagnostic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

antibody discoverysynthetic antibody librarydrug discoveryVHH librariessingle-domain antibodybiotech CROcontract research organizationantibody engineeringtherapeutic antibodiesCIS displaynext-generation sequencingNGSbiologics discoveryphage display alternativedrug development platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Isogenica Comparables

Compare Isogenica with similar companies based on industry and business-model similarity.

Isogenica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
YUMAB GmbH
87%
Crescendo Biologics Ltd.
82%
Adimab
82%

Isogenica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 6, 2008

Key People

Founding team and executive leadership

Marion Cubitt

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors grew 77% MoM.

  • May 2, 2025

    Monthly visitors increased 32% MoM.

Isogenica Filings

Explore SEC and related filing metadata, where available.

Isogenica filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Isogenica's valuation, stock price, and market status.

Is Isogenica a public or private company?

Isogenica is a private company.

What is the current stock price of Isogenica?

Isogenica is a private company with no public stock price. Caplight tracks Isogenica's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Isogenica worth (valuation)?

Valuation information for Isogenica is not publicly available.

Can I buy Isogenica stock?

Isogenica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Isogenica's last funding round?

Isogenica's most recent funding round was VC Round on May 6, 2008.

Who are the main investors in Isogenica?

Investor information for Isogenica is not publicly disclosed.

Will Isogenica IPO soon?

No public IPO plans have been announced for Isogenica.

How can I track Isogenica secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Isogenica's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range20
Year Founded2000
Last FundingMay 6, 2008

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?